These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9048239)

  • 1. The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation.
    Ditkoff EC; Prosser R; Zimmermann RC; Lindheim S; Sauer MV
    J Assist Reprod Genet; 1997 Feb; 14(2):92-6. PubMed ID: 9048239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.
    Ditkoff EC; Sauer MV
    Hum Reprod; 1996 May; 11(5):1035-7. PubMed ID: 8671386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
    Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
    J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V
    Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval.
    Meldrum DR; Wisot A; Hamilton F; Gutlay AL; Kempton WF; Huynh D
    Fertil Steril; 1989 Mar; 51(3):455-9. PubMed ID: 2493403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of progestins for programming assisted reproductive cycles and gonadotropin-releasing hormone agonist flare-up protocols in older patients.
    Gonzalez P; Maloul S; Ciuffardi I; Frederick JL; Balmaceda JP; Asch RH
    Fertil Steril; 1995 Feb; 63(2):249-51. PubMed ID: 7843425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills.
    Fisch B; Royburt M; Pinkas H; Avrech OM; Goldman GA; Bar J; Tadir Y; Ovadia J
    Isr J Med Sci; 1996 Dec; 32(12):1172-6. PubMed ID: 9007147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles.
    Gerli S; Remohi J; Partrizio P; Borrero C; Balmaceda JP; Silber SJ; Asch RH
    Hum Reprod; 1989 Oct; 4(7):746-8. PubMed ID: 2514191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.
    Kowalik A; Barmat L; Damario M; Liu HC; Davis O; Rosenwaks Z
    J Reprod Med; 1998 May; 43(5):413-7. PubMed ID: 9610463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
    Tsai HD; Chen CM; Lo HY; Chang CC
    Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
    Lindheim SR; Barad DH; Witt B; Ditkoff E; Sauer MV
    J Assist Reprod Genet; 1996 Oct; 13(9):745-7. PubMed ID: 8947826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins.
    Scott RT; Neal GS; Illions EH; Hayslip CA; Hofmann GE
    Fertil Steril; 1993 Aug; 60(2):247-53. PubMed ID: 8339819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.